Clinical TrialsSearch results
Number of results: 62426
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- MK-0616 Cardiovascular Outcomes Study
- hypercholesterolemia
- Tanaka Yoshiyuki
- 2023-09-14
Not yet recruiting
- A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE
- Systemic Lupus Erythematosus
- Yamazaki Hayato
- 2023-09-14
Not yet recruiting
- [M20-638] A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With Rituximab and Lenalidomide (R2) Compared to R2 in Subjects With Relapsed or Refractory Follicular Lymphoma (EPCORE FL-1)
- Follicular Lymphoma
- Satomi Natsuko
- 2023-09-14
Recruiting
- Active-Controlled, Parallel-Group Study of SJP-0135 in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
- Primary open angle glaucoma or Ocular hypertension
- Omatsu Kazunori
- 2023-09-14
Recruiting
- Research for correlation between ESA resistance and serum hepcidin concentration
- Anemia with CKD
- Mitobe Yuko
- 2023-09-13
Recruiting
- Inhibitory effect of local administration of Lactobacillus rhamnosus K03 (L8020) on peri-implantitis with suppuration
- Peri-implantitis Active
- Okada Shinsuke
- 2023-09-13
Not yet recruiting
- Randomized study of Mechanical Thrombectomy vs. best medical treatment for stroke at 24 to 72 hours of Last Known Well
- Stroke
- Kimura Kazumi
- 2023-09-12
Not yet recruiting
- Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 5)
- Multiple Myeloma
- Ishibashi Hideyasu
- 2023-09-12
Not yet recruiting
- Online medical consultations for patients with movement disorders
- Dystonia, Parkinson's disease
- Morigaki Ryoma
- 2023-09-12
Not yet recruiting
- ARCT-2301 Phase III Study
- Prevention of SARS-CoV-2 infection
- Yusuke Okada
- 2023-09-12